Concepedia

Manrose Singh

MS

Statistics

Publications

3

Citations

1.4K

H-Index

3

Active since

2016

Affiliations

Massachusetts Institute of Technology(Current)

Inserm

Université Paris-Saclay

Massachusetts General Hospital

Institut Gustave Roussy

Manrose Singh is an author at Massachusetts Institute of Technology specializing in pharmacology, protein kinase inhibitors, and lung cancer.

ORCID

Publications per year

2016–2020

3

Publications

3

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer

Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

, , +10

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors

Leila Dardaei, Hui Qin Wang, Manrose Singh et al. · Nature Medicine · 2018 · 202 citations · Full text

, , +16

Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CLpro of COVID-19 and Acts as Superoxide Radical Scavenger

Francesco Caruso, Manrose Singh, Stuart Belli et al. · International Journal of Molecular Sciences · 2020 · 26 citations · Full text

, , +16

1–3 of 3